Annual Long Term Debt
$670.00 M
+$4.20 M+0.63%
31 December 2023
Summary:
Edwards Lifesciences annual long term debt is currently $670.00 million, with the most recent change of +$4.20 million (+0.63%) on 31 December 2023. During the last 3 years, it has risen by +$2.30 million (+0.34%). EW annual long term debt is now -18.52% below its all-time high of $822.30 million, reached on 31 December 2016.EW Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$682.50 M
+$11.00 M+1.64%
30 September 2024
Summary:
Edwards Lifesciences quarterly long term debt is currently $682.50 million, with the most recent change of +$11.00 million (+1.64%) on 30 September 2024. Over the past year, it has increased by +$15.70 million (+2.35%). EW quarterly long term debt is now -33.99% below its all-time high of $1.03 billion, reached on 30 September 2017.EW Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EW Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.6% | +2.4% |
| 3 y3 years | +0.3% | +3.4% |
| 5 y5 years | +12.8% | +5.5% |
EW Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +0.8% | at high | +3.5% |
| 5 y | 5 years | at high | +12.8% | at high | +5.5% |
| alltime | all time | -18.5% | +985.9% | -34.0% | +1084.9% |
Edwards Lifesciences Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $682.50 M(+1.6%) |
| June 2024 | - | $671.50 M(-0.4%) |
| Mar 2024 | - | $674.40 M(+0.7%) |
| Dec 2023 | $670.00 M(+0.6%) | $670.00 M(+0.5%) |
| Sept 2023 | - | $666.80 M(+1.0%) |
| June 2023 | - | $660.20 M(-0.4%) |
| Mar 2023 | - | $662.70 M(-0.5%) |
| Dec 2022 | $665.80 M(+0.2%) | $665.80 M(+0.4%) |
| Sept 2022 | - | $663.30 M(+0.6%) |
| June 2022 | - | $659.50 M(-0.7%) |
| Mar 2022 | - | $664.30 M(-0.1%) |
| Dec 2021 | $664.80 M(-0.4%) | $664.80 M(+0.7%) |
| Sept 2021 | - | $659.90 M(+0.1%) |
| June 2021 | - | $659.10 M(-0.5%) |
| Mar 2021 | - | $662.30 M(-0.8%) |
| Dec 2020 | $667.70 M(+2.2%) | $667.70 M(+0.3%) |
| Sept 2020 | - | $665.90 M(+0.8%) |
| June 2020 | - | $660.70 M(+1.6%) |
| Mar 2020 | - | $650.30 M(-0.5%) |
| Dec 2019 | $653.30 M(+10.0%) | $653.30 M(+1.0%) |
| Sept 2019 | - | $646.60 M(+0.3%) |
| June 2019 | - | $644.50 M(+0.1%) |
| Mar 2019 | - | $643.60 M(+8.4%) |
| Dec 2018 | $593.80 M(+35.4%) | $593.80 M(+0.0%) |
| Sept 2018 | - | $593.60 M(-0.1%) |
| June 2018 | - | $593.90 M(+30.2%) |
| Mar 2018 | - | $456.00 M(+4.0%) |
| Dec 2017 | $438.40 M(-46.7%) | $438.40 M(-57.6%) |
| Sept 2017 | - | $1.03 B(+1.7%) |
| June 2017 | - | $1.02 B(+19.9%) |
| Mar 2017 | - | $847.90 M(+3.1%) |
| Dec 2016 | $822.30 M(+37.8%) | $822.30 M(+36.9%) |
| Sept 2016 | - | $600.60 M(-0.3%) |
| June 2016 | - | $602.50 M(+0.0%) |
| Mar 2016 | - | $602.20 M(+0.9%) |
| Dec 2015 | $596.90 M(-0.2%) | $596.90 M(-1.3%) |
| Sept 2015 | - | $604.90 M(+0.8%) |
| June 2015 | - | $600.30 M(-0.4%) |
| Mar 2015 | - | $602.70 M(+0.8%) |
| Dec 2014 | $598.10 M(+0.8%) | $598.10 M(+0.3%) |
| Sept 2014 | - | $596.40 M(-0.3%) |
| June 2014 | - | $598.00 M(-17.6%) |
| Mar 2014 | - | $725.40 M(+22.3%) |
| Dec 2013 | $593.10 M(+213.3%) | $593.10 M(+11.5%) |
| Sept 2013 | - | $532.10 M(+134.1%) |
| June 2013 | - | $227.30 M(+18.0%) |
| Mar 2013 | - | $192.70 M(+1.8%) |
| Dec 2012 | $189.30 M | $189.30 M(+7.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2012 | - | $175.40 M(-5.2%) |
| June 2012 | - | $185.10 M(+3.2%) |
| Mar 2012 | - | $179.40 M(+19.3%) |
| Dec 2011 | $150.40 M(+66.6%) | $150.40 M(-14.1%) |
| Sept 2011 | - | $175.00 M(+0.1%) |
| June 2011 | - | $174.80 M(-1.5%) |
| June 2010 | - | $177.50 M(+37.3%) |
| Mar 2010 | - | $129.30 M(+43.2%) |
| Dec 2009 | $90.30 M(-48.5%) | $90.30 M(-11.7%) |
| Sept 2009 | - | $102.30 M(-10.2%) |
| June 2009 | - | $113.90 M(-7.4%) |
| Mar 2009 | - | $123.00 M(-29.9%) |
| Dec 2008 | $175.50 M(+184.4%) | $175.50 M(-13.5%) |
| Sept 2008 | - | $202.80 M(+43.1%) |
| June 2008 | - | $141.70 M(+125.3%) |
| Mar 2008 | - | $62.90 M(+1.9%) |
| Dec 2007 | $61.70 M(-73.8%) | $61.70 M(+0.8%) |
| Sept 2007 | - | $61.20 M(+6.3%) |
| June 2007 | - | $57.60 M(-74.3%) |
| Mar 2007 | - | $224.50 M(-4.8%) |
| Dec 2006 | $235.90 M(-25.4%) | $235.90 M(-6.8%) |
| Sept 2006 | - | $253.00 M(-9.5%) |
| June 2006 | - | $279.60 M(-3.3%) |
| Mar 2006 | - | $289.00 M(-8.6%) |
| Dec 2005 | $316.10 M(+18.3%) | $316.10 M(+25.7%) |
| Sept 2005 | - | $251.50 M(-6.7%) |
| June 2005 | - | $269.60 M(-2.2%) |
| Mar 2005 | - | $275.80 M(+3.3%) |
| Dec 2004 | $267.10 M(+4.4%) | $267.10 M(-0.8%) |
| Sept 2004 | - | $269.20 M(-13.9%) |
| June 2004 | - | $312.80 M(-6.5%) |
| Mar 2004 | - | $334.50 M(+30.8%) |
| Dec 2003 | $255.80 M(+4.2%) | $255.80 M(-12.7%) |
| Sept 2003 | - | $293.10 M(-4.6%) |
| June 2003 | - | $307.30 M(+11.0%) |
| Mar 2003 | - | $276.90 M(+12.8%) |
| Dec 2002 | $245.50 M(-20.8%) | $245.50 M(-12.3%) |
| Sept 2002 | - | $279.90 M(-5.7%) |
| June 2002 | - | $296.90 M(+2.1%) |
| Mar 2002 | - | $290.80 M(-6.1%) |
| Dec 2001 | $309.80 M(-15.6%) | $309.80 M(-8.6%) |
| Sept 2001 | - | $339.10 M(+0.0%) |
| June 2001 | - | $339.00 M(-3.9%) |
| Mar 2001 | - | $352.90 M(-3.8%) |
| Dec 2000 | $367.00 M | $367.00 M(+5.4%) |
| Sept 2000 | - | $348.20 M(+8.5%) |
| June 2000 | - | $321.00 M(+0.6%) |
| Mar 2000 | - | $319.00 M |
FAQ
- What is Edwards Lifesciences annual long term debt?
- What is the all time high annual long term debt for Edwards Lifesciences?
- What is Edwards Lifesciences annual long term debt year-on-year change?
- What is Edwards Lifesciences quarterly long term debt?
- What is the all time high quarterly long term debt for Edwards Lifesciences?
- What is Edwards Lifesciences quarterly long term debt year-on-year change?
What is Edwards Lifesciences annual long term debt?
The current annual long term debt of EW is $670.00 M
What is the all time high annual long term debt for Edwards Lifesciences?
Edwards Lifesciences all-time high annual long term debt is $822.30 M
What is Edwards Lifesciences annual long term debt year-on-year change?
Over the past year, EW annual long term debt has changed by +$4.20 M (+0.63%)
What is Edwards Lifesciences quarterly long term debt?
The current quarterly long term debt of EW is $682.50 M
What is the all time high quarterly long term debt for Edwards Lifesciences?
Edwards Lifesciences all-time high quarterly long term debt is $1.03 B
What is Edwards Lifesciences quarterly long term debt year-on-year change?
Over the past year, EW quarterly long term debt has changed by +$15.70 M (+2.35%)